AssetMark Inc’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-81
Closed -$3.29K 3468
2025
Q4
$3.29K Buy
+81
New +$3.52K ﹤0.01% 2615
2025
Q2
Sell
-81
Closed -$4.89K 3029
2025
Q1
$4.89K Buy
+81
New +$5.22K ﹤0.01% 1999
2018
Q1
Sell
-8
Closed 1512
2017
Q4
$0 Buy
+8
New +$417 ﹤0.01% 1908

Other funds holding CNMD

AssetMark Inc's CNMD Position: Q1 2026 in Review

AssetMark Inc sold out of CONMED (CNMD) in Q1 2026, closing a stake of 81 shares — an estimated $3.29K sold.

AssetMark Inc first reported a position in CNMD in Q4 2017 and held it in 3 quarters. The position peaked at $4.89K in Q1 2025. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • AssetMark Inc reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • AssetMark Inc sold 81 CONMED shares in Q1 2026, an estimated $3.29K.
  • AssetMark Inc first reported a position in CONMED in Q4 2017 and held it in 3 quarters.
  • AssetMark Inc's CONMED position peaked at $4.89K in Q1 2025.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on AssetMark Inc's 13F filing for Q1 2026, filed 6 May 2026.